These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15936831)

  • 1. Fundamental considerations of beta-adrenoceptor subtypes in human heart failure.
    Molenaar P; Parsonage WA
    Trends Pharmacol Sci; 2005 Jul; 26(7):368-75. PubMed ID: 15936831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M; Brodde OE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE; Daul A; Michel MC; Zerkowski HR
    Z Kardiol; 1992; 81 Suppl 4():71-8. PubMed ID: 1363262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-adrenoceptor antagonists in the treatment of chronic heart failure].
    Bundkirchen A; Brixius K; Schwinger RH
    Pharmazie; 2004 Feb; 59(2):83-92. PubMed ID: 15025174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-adrenergic receptors of the normal heart and in heart failure].
    Krasnikov TL; Gabrusenko SA
    Usp Fiziol Nauk; 2000; 31(2):35-50. PubMed ID: 10822833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ; Engelhardt S; Eschenhagen T
    Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-adrenergic receptors in the cardiovascular system. The participation of propranolol insensitive beta-adrenoceptors in the regulation of the cardiovascular system].
    Malinowska B; Kozłowska H; Zakrzeska A; Kwolek G
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S399-408. PubMed ID: 20527395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of myocardial beta-adrenergic receptors in cardiac insufficiency].
    Gibelin P; Sbirrazzuoli V; Drici M; Bossan P; Baudouy M; Lapalus P; Morand P
    Ann Cardiol Angeiol (Paris); 1990 Mar; 39(3):165-71. PubMed ID: 2160789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart.
    Gourine A; Bondar SI; Spyer KM; Gourine AV
    Circ Res; 2008 Mar; 102(6):633-6. PubMed ID: 18323523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Place of beta 3-adrenoceptors among other beta-adrenoceptor subtypes in the regulation of the cardiovascular system.
    Rozec B; Noireaud J; Trochu JN; Gauthier C
    Arch Mal Coeur Vaiss; 2003 Sep; 96(9):905-13. PubMed ID: 14571645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a secondary state of the human beta3-adrenoceptor.
    Baker JG
    Mol Pharmacol; 2005 Dec; 68(6):1645-55. PubMed ID: 16129733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta receptors and beta blockers in heart failure].
    Heinzl S
    Med Monatsschr Pharm; 1997 Jun; 20(6):146-8. PubMed ID: 9289626
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic heart failure with beta-adrenoceptor antagonists. Guideline-based optimization with ERICA, a quality register].
    Antoni DH; Beuckelmann D; Hambrecht R; Nowak F; Schuchert D; Schwinger RH
    Dtsch Med Wochenschr; 2002 Nov; 127(46):2459-63. PubMed ID: 12432488
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation.
    Bassiakou E; Xanthos T; Papadimitriou L
    Eur J Pharmacol; 2009 Aug; 616(1-3):1-6. PubMed ID: 19555681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties.
    Taira CA; Carranza A; Mayer M; Di Verniero C; Opezzo JA; Höcht C
    Curr Clin Pharmacol; 2008 Sep; 3(3):174-84. PubMed ID: 18781904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta(3)-Adrenoceptor antagonism improves clinical outcomes of chronic heart failure.
    Wu T; Wang L
    Med Hypotheses; 2007; 69(5):1114-6. PubMed ID: 17428618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta3-adrenergic stimulation in the human heart: signal transduction, functional implications and therapeutic perspectives.
    Pott C; Brixius K; Bloch W; Ziskoven C; Napp A; Schwinger RH
    Pharmazie; 2006 Apr; 61(4):255-60. PubMed ID: 16649533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta(1)-adrenoceptor polymorphisms: deviation of clinical outcome with use of beta-blockers in ventricular dysfunction.
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):145-7. PubMed ID: 18248268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.